Medicare Enrolled

Dr. Morteza Dowlatshahi, M.D.

Radiology - Diagnostic · San Jose, CA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
200 JOSE FIGUERES AVE, San Jose, CA 95116
4087294673
In practice since 2006 (19 years)
NPI: 1437112158 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Dowlatshahi from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Dowlatshahi? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Dowlatshahi

Dr. Morteza Dowlatshahi is a radiology - diagnostic specialist in San Jose, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Dowlatshahi performed 516 Medicare services across 132 unique beneficiaries.

Between the years covered by Open Payments, Dr. Dowlatshahi received a total of $6,560 from 51 pharmaceutical and/or device companies across 282 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in radiology - diagnostic. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Dowlatshahi is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ 516 Medicare services $6,560 industry payments

Medicare Practice Summary

Medicare Utilization ↗
516
Medicare services
Bottom 19% in CA for radiology - diagnostic
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
132
Unique beneficiaries
$239
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~27 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Intensity-modulated radiation therapy delivery
Delivery of radiation therapy using narrow beams that are spatially and temporally modulated to target specific areas. This process is performed per treatment session.
221 $400 $2,045
Calculation of radiation therapy dose 67 $57 $276
Continuing radiation therapy consultation per week
A weekly consultation to review and manage ongoing radiation therapy treatment.
61 $93 $459
Radiation treatment management, 5 sessions
Oversight and management of a radiation therapy course consisting of five treatment sessions.
61 $178 $870
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
43 $113 $417
Design and construction of complex radiation treatment device
This code covers the design and construction of a complex radiation treatment device. It does not specify the clinical purpose or conditions treated.
27 $119 $570
Complex radiation therapy planning 18 $153 $736
New patient office visit, complex (60-74 min) 18 $207 $682
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$6,560
Total received (2018-2024)
Avg $937/year across 7 years
Top 14% in CA for radiology - diagnostic
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
51
Companies
282
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$6,261 (95.4%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$299 (4.6%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$906
2023
$1,104
2022
$1,322
2021
$809
2020
$637
2019
$924
2018
$857

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Janssen Biotech, Inc.
$146
AstraZeneca Pharmaceuticals LP
$135
Novartis Pharmaceuticals Corporation
$124
Merck Sharp & Dohme LLC
$78
PFIZER INC.
$57
PROGENICS PHARMACEUTICALS, INC.
$53
Daiichi Sankyo Inc.
$36
Deciphera Pharmaceuticals Inc.
$36
EMD Serono, Inc.
$34
Regeneron Healthcare Solutions, Inc.
$33
Coherus Biosciences Inc.
$28
SOBI, INC
$28
Genmab U.S., Inc.
$28
ABBVIE INC.
$24
Takeda Pharmaceuticals U.S.A., Inc.
$24
Astellas Pharma US Inc
$21
Boehringer Ingelheim Pharmaceuticals, Inc.
$20
Top 3 companies account for 44.7% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$845
Janssen Biotech, Inc.
$842
Novartis Pharmaceuticals Corporation
$587
PFIZER INC.
$413
E.R. Squibb & Sons, L.L.C.
$360
Takeda Pharmaceuticals U.S.A., Inc.
$316
Lilly USA, LLC
$257
Merck Sharp & Dohme LLC
$241
Astellas Pharma US Inc
$237
Seagen Inc.
$195
GlaxoSmithKline, LLC.
$144
Celgene Corporation
$144
Novocure Inc.
$139
Merck Sharp & Dohme Corporation
$133
Amgen Inc.
$122
Medtronic, Inc.
$116
EMD Serono, Inc.
$112
Clovis Oncology, Inc.
$103
Daiichi Sankyo Inc.
$92
Foundation Medicine, Inc.
$91
Bayer HealthCare Pharmaceuticals Inc.
$83
Progenics Pharmaceuticals, Inc.
$67
Regeneron Healthcare Solutions, Inc.
$64
Elekta, Inc.
$58
Seattle Genetics, Inc.
$54
PROGENICS PHARMACEUTICALS, INC.
$53
Boehringer Ingelheim Pharmaceuticals, Inc.
$46
Puma Biotechnology, Inc.
$45
Dova Pharmaceuticals
$45
Eisai Inc.
$41
Rigel Pharmaceuticals, Inc.
$40
ARRAY BIOPHARMA INC
$39
Deciphera Pharmaceuticals Inc.
$36
Coherus Biosciences Inc.
$28
SOBI, INC
$28
Genmab U.S., Inc.
$28
Blueprint Medicines Corporation
$26
EISAI INC.
$25
ABBVIE INC.
$24
GENZYME CORPORATION
$24
Bayer Healthcare Pharmaceuticals Inc.
$24
PUMA BIOTECHNOLOGY, INC.
$24
Genentech USA, Inc.
$24
Blue Earth Diagnostics Limited
$22
Array BioPharma Inc.
$22
Pharmacyclics LLC, An AbbVie Company
$22
PALETTE LIFE SCIENCES, INC.
$21
Janssen Scientific Affairs, LLC
$21
Incyte Corporation
$21
Vyera Pharmaceuticals, LLC
$16
MEDIVATION FIELD SOLUTIONS LLC
$2
Top 3 companies account for 34.7% of all-time payments
Associated products mentioned in payments ›
ABIRATERONE ACETATE TABLETS · ADCETRIS · ALUNBRIG · AYVAKIT · Abraxane · Axumin · BAVENCIO · BLENREP · BRAFTOVI · Bavencio · Braftovi · CALQUENCE · CYRAMZA · DARZALEX · Daraprim 30 Tablet in 1 Bottle · Doptelet · EEA · ELEKTA UNITY · EMPLICITI · ENHERTU · ERLEADA · Enhertu · Epkinly · Erleada · FOUNDATIONONE · FRUZAQLA · GILOTRIF · IBRANCE · IMBRUVICA · IMFINZI · INLYTA · INREBIC · JADENU · KEYTRUDA · KISQALI · Kyprolis · LIBTAYO · LIBTAYO CEMIPLIMAB-RWLC INJECTION · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · MEKINIST · MONJUVI · NERLYNX · NINLARO · Nerlynx · Nplate · Nubeqa · OPDIVO · Oncology · PADCEV · PLUVICTO · PROMACTA · PYLARIFY · Padcev · Pomalyst · QINLOCK · RYDAPT · Revlimid · Rezlidhia · Rubraca · SARCLISA · SCEMBLIX · SPRYCEL · TAGRISSO · TASIGNA · TECVAYLI · TEPMETKO · TUKYSA · Tavalisse · Udenyca · VELCADE · VERZENIO · VONJO · VOTRIENT · Versa HD · XTANDI · Xofigo · ZEJULA · ZYTIGA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (95%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a radiology - diagnostic specialist in San Jose?
Compare radiology - diagnostics in the San Jose area by procedure volume, costs, and industry payment transparency.
Browse radiology - diagnostics nearby

Geographic Context

Radiology - diagnostics within 10 mi
79
Per 100K population
4.2
County median income
$159,674
Nearest hospital
REGIONAL MEDICAL CENTER OF SAN JOSE
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Dowlatshahi is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement in the top 14% of CA peers, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Dowlatshahi experienced with intensity-modulated radiation therapy delivery?
Based on Medicare claims data, Dr. Dowlatshahi performed 221 intensity-modulated radiation therapy delivery services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Dowlatshahi receive payments from pharmaceutical companies?
Yes. Dr. Dowlatshahi received a total of $6,560 from 51 companies across 282 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Dowlatshahi's costs compare to other radiology - diagnostics in San Jose?
Dr. Dowlatshahi's average Medicare payment per service is $239. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Dowlatshahi) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →